Aranda Eduardo, Iha Seiki, Solari Sandra, Rodríguez David, Romero Viviana, Villarroel Luis, Pereira Jaime, Panes Olga, Mezzano Diego
Department of Hematology-Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Department of Clinical Laboratory, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Res Pract Thromb Haemost. 2023 Jul 24;7(5):102156. doi: 10.1016/j.rpth.2023.102156. eCollection 2023 Jul.
Mild secretion defects are the most frequent and challenging blood platelet disorders to diagnose. Most δ-granule secretion tests lack validation, are not quantitative, or have unreliable response to weak platelet agonists.
To compare platelet serotonin secretion by HPLC-electrochemical detection technique (HPLC-ECD) with the reference isotopic test (H-5-HT), evaluating its performance in clinical laboratories.
The assay validation followed STARD-2015 recommendations. HPLC-ECD measured the nonsecreted serotonin remaining in platelet pellets after aggregation, comparing it with the reference H-5-HT assay. We studied subjects with inherited and aspirin-induced blood platelet disorders and assessed the HPLC-ECD operation for routine clinical diagnosis.
Calibration curves were linear (R = 0.997), with SD for residuals of 3.91% and analytical sensitivity of 5ng/mL. Intra- and interassay imprecision bias ranged between -8.5% and 2.1% and -9% and 3.1%, respectively. Serotonin recovery and stability were >95%, and the variability range of measurements was -5.5% to 4.6%. Statistical differences detected between tests were biologically irrelevant, with bias of 1.48% (SD, 8.43) and CI agreement of -18% to 15%. Both assays distinctly detected platelet secretion induced by 10 μM epinephrine and 4 μmM adenosine diphosphate. However, HPLC-ECD is quantitative and more sensitive to low serotonin content in blood platelets. Reference cutoffs for each agonist were determined in 87 subjects. Initially, the HPLC-ECD requires relatively expensive equipment and trained operators but has remarkably cheap running costs and a turn-around time of 24-36 hours. We have used this diagnostic tool routinely for >8 years.
HPLC-ECD assay for platelet serotonin secretion is highly accurate, has advantages over the reference H-5-HT test, and is suitable as a clinical laboratory technique.
轻度分泌缺陷是最难诊断的血小板疾病,也是最常见的血小板疾病。大多数δ-颗粒分泌试验缺乏验证,不是定量的,或者对弱血小板激动剂的反应不可靠。
采用高效液相色谱-电化学检测技术(HPLC-ECD)与参考同位素试验(H-5-HT)比较血小板5-羟色胺分泌情况,评估其在临床实验室的性能。
检测方法验证遵循STARD-2015建议。HPLC-ECD检测聚集后血小板沉淀中剩余的未分泌5-羟色胺,并与参考H-5-HT检测进行比较。我们研究了患有遗传性和阿司匹林诱导的血小板疾病的受试者,并评估了HPLC-ECD用于常规临床诊断的操作情况。
校准曲线呈线性(R = 0.997),残差标准差为3.91%,分析灵敏度为5ng/mL。批内和批间不精密度偏差分别在-8.5%至2.1%和-9%至3.1%之间。5-羟色胺回收率和稳定性>95%,测量变异范围为-5.5%至4.6%。检测之间的统计学差异在生物学上不相关,偏差为1.48%(标准差,8.43),一致性区间为-18%至15%。两种检测方法均能清晰检测到10μM肾上腺素和4μM二磷酸腺苷诱导的血小板分泌。然而,HPLC-ECD是定量的,对血小板中低含量的5-羟色胺更敏感。在87名受试者中确定了每种激动剂的值。最初,HPLC-ECD需要相对昂贵的设备和经过培训的操作人员,但运行成本非常低,周转时间为24-36小时。我们已经将这种诊断工具常规使用了8年多。
HPLC-ECD检测血小板5-羟色胺分泌高度准确,优于参考H-5-HT检测,适合作为临床实验室技术。